NeuralCipher Open access
Targeting mitochondria for the treatment of neurodegenerative diseases.
DOI: 10.3389/fnins.2026.1835506PMID: 42553297
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
20.386 articles found
Source record
Hyperoside Exerts Therapeutic Effects on Parkinson's Disease by Mitigating Oxidative Stress through Activation of Nrf2/HO-1 Pathway.
DOI: 10.1007/s11655-026-4160-6PMID: 42479115
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Population pharmacokinetic analyses comparing immediate-release levodopa/carbidopa, controlled-release levodopa/carbidopa, and IPX203. Findings from a phase 1 study in healthy volunteers.
DOI: 10.1007/s00702-026-03233-wPMID: 42479139
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Molecular Mechanisms and Therapeutic Strategies in Parkinson's Disease: From Pathogenic Signaling to Drug Development.
DOI: 10.2174/011570159x457429260706102249PMID: 42509706
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Lithium as a Potential Neuroprotective Strategy in Glaucoma: Mechanisms and Therapeutic Perspectives.
DOI: 10.3390/biom16071062PMID: 42509854
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Focused Ultrasound Blood-Brain Barrier Opening for Targeted Therapeutics in Neurodegenerative Diseases.
DOI: 10.1016/j.biopsych.2026.07.008PMID: 42468901
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Crosstalk Between Parkinson's Disease and Colorectal Cancer: Genetic Mechanisms, Gut Microbiota, and Therapeutic Insights.
DOI: 10.1002/hcs2.70087PMID: 42499636
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Adjunctive EGb 761 treatment in patients with Parkinson's disease: a case series.
DOI: 10.3389/fnagi.2026.1767148PMID: 42539673
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Targeting neuroinflammation and neurodegeneration in Parkinson's disease: Emerging natural and synthetic therapeutic strategies.
DOI: 10.1016/j.arr.2026.103263PMID: 42468577
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Dual-acting molecular hybrid strategy: A dopamine D2 receptor agonist with synergistic anti-ferroptosis activity for the treatment of Parkinson's disease.
DOI: 10.1016/j.ejmech.2026.119169PMID: 42480356
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Gut microbiota-nanoparticle interactions in Parkinson's disease: mechanistic insights and therapeutic perspective.
DOI: 10.1080/21691401.2026.2694921PMID: 42466852
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Nanoparticles Navigating the Blood-Brain Barrier for Neurodegenerative Therapy.
DOI: 10.2147/ijn.s620793PMID: 42518684
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.